Purina, through its 9Square Ventures corporate venturing group, has named PetPax Co. the grand prize winner of the 2026 Pet Care Innovation Prize. This honour follows a live pitch competition at Global Pet Expo, with the Boston-based startup securing an additional $25,000 cash award on top of the initial non-dilutive funding and mentorship already provided through the program.
PetPax Co. specializes in a product line called SupplaMelts, which uses a proprietary fast-dissolving oral thin-film delivery method to administer veterinarian-approved supplements to dogs in a form that bypasses stomach acid. This ensures improved absorption while reducing the stress associated with traditional pill or liquid dosing. The company’s offerings include formulations such as ZenMelts for calming support and DentalMelts for oral health.
Four other startups were recognized as part of the 2026 Pet Care Innovation Prize.
Image Credit: Purina
What Makes This Trend Stand Out
- Oral Thin-film Delivery
- A shift toward fast-dissolving oral thin films for pets indicates potential to replace pills by enabling precise, palatable, and gastric-bypassable supplement delivery.
- Stress-free Dosing
- Consumers favor low-stress dosing options that reduce administration anxiety and create opportunities for products that integrate behavioral science with delivery formats.
- Functional Meltable Treats
- Fusing functional ingredients into meltable treat formats signals room for category expansion of targeted health benefits like dental care and calming support.
Sectors Adopting This
- Veterinary Pharmaceuticals
- Novel delivery technologies could upend traditional formulations by improving bioavailability and compliance for prescription and OTC pet medications.
- Pet Tech and Wellness
- The convergence of wellness-focused formulations with user-friendly dosage formats suggests new product lines and subscription services optimizing pet health routines.
- Corporate Venturing in Petcare
- Corporate venture programs that accelerate startups reveal a landscape where strategic partnerships and non-dilutive support can rapidly commercialize disruptive pet innovations.
